Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Viti

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
World Journal of Urology|June 13, 2026
Serenoa Repens-Lycopene-Selenium and Epilobium-Palmitoylethanolamide-Calendula after transperineal prostate biopsy: a tertiary single center experiencePaolo Zaurito, Pietro Scilipoti, Armando Stabile, et al.
European Urology Oncology|December 22, 2025
Impact of Implementation of Risk Calculators for the Selection of Extended Pelvic Lymph Node Dissection Candidates: 20-year Experience from a Tertiary Referral CentreFrancesco Barletta, Simone Scuderi, Pietro Scilipoti, et al.
European Urology Oncology|July 11, 2025
Incidence and Predictors of Acute Kidney Injury and Acute Kidney Disease After Robot-assisted Radical Prostatectomy in Prostate Cancer PatientsPaolo Zaurito, Alexandre Calado, Leonardo Quarta, et al.
World Journal of Urology|November 2, 2025
Management and recurrence patterns of radiation-induced cystitis with hematuria: a persistent clinical challengeMario de Angelis, Leonardo Quarta, Mattia Longoni, et al.
BJU International|August 22, 2025
The value of maintenance therapy in intermediate-risk non-muscle-invasive bladder cancerPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
Urologic Oncology|February 14, 2026
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathwayPietro Scilipoti, Giuseppe Rosiello, Alfonso Santangelo, et al.
Cancers|May 27, 2026
Prostate Cancer Screening in Contemporary Era: PSA-Based Testing and Risk-Adapted ApproachesMichele Brancaccio, Armando Galdieri, Andrea Cosenza, et al.
European Urology Focus|December 24, 2025
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?Leonardo Quarta, Francesco Pellegrino, Armando Stabile, et al.
World Journal of Urology|November 8, 2025
Impact of timing between neoadjuvant therapy and radical cystectomy on survival in muscle-invasive bladder cancerPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Vascular Pharmacology|July 10, 2024
Early impairment in mitochondrial quality check and function precedes the development of cardiac phenotypes in an mouse model of Fabry DiseaseJessica Gambardella, Antonella Fiordelisi, Federica Andrea Cerasuolo, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
World Journal of Urology|June 13, 2026
Serenoa Repens-Lycopene-Selenium and Epilobium-Palmitoylethanolamide-Calendula after transperineal prostate biopsy: a tertiary single center experiencePaolo Zaurito, Pietro Scilipoti, Armando Stabile, et al.
European Urology Oncology|December 22, 2025
Impact of Implementation of Risk Calculators for the Selection of Extended Pelvic Lymph Node Dissection Candidates: 20-year Experience from a Tertiary Referral CentreFrancesco Barletta, Simone Scuderi, Pietro Scilipoti, et al.
European Urology Oncology|July 11, 2025
Incidence and Predictors of Acute Kidney Injury and Acute Kidney Disease After Robot-assisted Radical Prostatectomy in Prostate Cancer PatientsPaolo Zaurito, Alexandre Calado, Leonardo Quarta, et al.
World Journal of Urology|November 2, 2025
Management and recurrence patterns of radiation-induced cystitis with hematuria: a persistent clinical challengeMario de Angelis, Leonardo Quarta, Mattia Longoni, et al.
BJU International|August 22, 2025
The value of maintenance therapy in intermediate-risk non-muscle-invasive bladder cancerPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
Urologic Oncology|February 14, 2026
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathwayPietro Scilipoti, Giuseppe Rosiello, Alfonso Santangelo, et al.
Cancers|May 27, 2026
Prostate Cancer Screening in Contemporary Era: PSA-Based Testing and Risk-Adapted ApproachesMichele Brancaccio, Armando Galdieri, Andrea Cosenza, et al.
European Urology Focus|December 24, 2025
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?Leonardo Quarta, Francesco Pellegrino, Armando Stabile, et al.
World Journal of Urology|November 8, 2025
Impact of timing between neoadjuvant therapy and radical cystectomy on survival in muscle-invasive bladder cancerPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Vascular Pharmacology|July 10, 2024
Early impairment in mitochondrial quality check and function precedes the development of cardiac phenotypes in an mouse model of Fabry DiseaseJessica Gambardella, Antonella Fiordelisi, Federica Andrea Cerasuolo, et al.
Pageof 3